Founded in 1939, Atabay is a well-established pharmaceutical and fine chemicals company with headquarters and production facilities in Istanbul, as well as a manufacturing site in the industrial zone of Kocaeli. With robust technical expertise in API production and a strong presence in the manufacturing of generic drug products, Atabay ranks as the sixth-largest pharmaceutical producer in Türkiye by volume.

Over the past decade, Atabay has made significant investments in R&D and manufacturing biological products. Our portfolio includes a range of biologics at various stages of development, all produced in our GMP-certified biotechnology facility. In parallel, we continue to develop new biosimilars as well as novel biologic products through in-house research and development.

With a highly qualified team and a well-established infrastructure, Atabay provides versatile
solutions in the field of biotechnology. We are currently seeking to build strategic partnerships with global players to expand our reach and collaborate on innovative projects.

Complete Expert Services
  • Microbial Cell Line Development
  • Upstream and Downstream Process Development
  • Analytical Method Development
  • cGMP Microbial Vaccine Processes
  • cGMP Microbial Biosimilar Processes
  • cGMP Microbial Upstream Processes
  • cGMP Microbial Downstream Processes
  • cGMP Manufacturing Process Validation
  • Sterile Syringe Filling Line
  • Biosimilar Characterization Analysis
  • Finished Medicinal Product Analysis
Biosimilars (R&D and Production)
  • Ranibizumab (Bacterial)
  • Semaglutide (Bacterial)
  • G-CSF (Bacterial)
Biotechnology Product
  • Enoxaparin (Fill & Finish)
Vaccine Technology
  • COVID-19 Recombinant RBD vaccine
  • COVID-19 Plasmid DNA vaccine
  • Menengitis vaccine

1

2

3

4

5

6

7

8

9

10